Citius Pharmaceuticals, Inc.
General ticker "CTXR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.2M (TTM average)
Citius Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 7.9%.
Estimated limits based on current volatility of 2.2%: low 0.81$, high 0.86$
Factors to consider:
- Total employees count: 22 as of 2023
- Top business risk factors: Net losses, Fundraising challenges, Regulatory and compliance, Operational and conduct risks, Acquisition/divestiture risks
- Current price 82.5% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [6.71$, 19.04$]
- 2025-09-30 to 2026-09-30 estimated range: [4.89$, 14.26$]
Financial Metrics affecting the CTXR estimates:
- Negative: with PPE of -2.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -18.45 <= 0.04
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -20.18 <= 0
- Negative: Inventory ratio change, % of 100 > 0.82
- Positive: 42.53 < Shareholder equity ratio, % of 60.07 <= 64.17
Short-term CTXR quotes
Long-term CTXR plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $33.32MM | $36.73MM | $42.00MM |
| Operating Income | $-33.32MM | $-36.73MM | $-42.00MM |
| Non-Operating Income | $0.25MM | $4.77MM | $3.15MM |
| R&D Expense | $17.66MM | $14.82MM | $11.91MM |
| Income(Loss) | $-33.06MM | $-31.97MM | $-38.85MM |
| Taxes | $0.58MM | $0.58MM | $0.58MM |
| Profit(Loss)* | $-33.64MM | $-32.54MM | $-39.14MM |
| Stockholders Equity | $102.83MM | $90.83MM | $70.08MM |
| Inventory | $0.00MM | $0.00MM | $8.27MM |
| Assets | $114.00MM | $103.61MM | $116.65MM |
| Operating Cash Flow | $-28.36MM | $-29.06MM | $-28.20MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-5.00MM |
| Financing Cash Flow | $0.00MM | $13.83MM | $9.97MM |
| Earnings Per Share** | $-3.45 | $-3.34 | $-3.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.